Silence Therapeutics - A Revolution in Gene Silencing

All the latest and archived news releases and events

Current News Releases

 Press Releases 2009

Events

 Upcoming Events

 Past Events 

Archived New Releases

 Press Releases 2008

 Press Releases 2007

 Press Releases 2006

 Press Releases 2005

 Press Releases 2004

 Press Releases 2003

 Press Releases 2002

 Press Releases 2001

 Press Releases 2000

 

 

 

 

 

Document Last Updated ( Monday, 28 December 2009 )
 
Contact Legal Disclaimer Company Info © Silence Therapeutics 2007

In Brief

8 February 2010
Silence Therapeutics Receives Notice of Allowance for RNAi Patent Covering Novel Cancer Target

   Read more...
 

5 February 2010
Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference

   Read more...
 

5 January 2010
Silence and Intradigm complete merger to form a leading company in the field of RNAi

   Read more...
 

4 January 2010
Shareholders pass all resolutions at EGM

   Read more...
 

16 December 2009
Silence Therapeutics to merge with Intradigm Corp to create leading RNAi therapeutics company

   Read more...
 

16 December 2009
Admission Document – Circular to Shareholders in full
download Admission Document

 

14 December 2009
Shareholders pass all resolutions at AGM

   Read more...
 

15 October 2009
Silence Therapeutics’ core patent upheld

   Read more...
 

30 September 2009
Silence announces Interim Results for the six months ended 30 June 2009

   Read more...
 

29 September 2009
Silence announces temporary suspension of shares pending outcome of M&A talks

   Read more...
 

17 September 2009
Silence will release its interim results for the 6 months to 30 June 2009 on 30 September 2009

   Read more...
 

27 August 2009
Silence Therapeutics signs siRNA delivery collaboration with Dainippon Sumitomo Pharma

   Read more...
 

23 June 2009
Silence announces dosing of first patient in Atu027 cancer trial

   Read more...
 

3 June 2009
Silence receives approval to commence Phase I clinical trial with Atu027

   Read more...
 

21 January 2009
Successful oppostion to 2nd EP on Keutzer-Limmer

   Read more...
 

9 January 2009
EPO grants Silence Therapeutics’ Patent

   Read more...